Correlation Between Hofseth Biocare and Arcticzymes Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hofseth Biocare and Arcticzymes Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hofseth Biocare and Arcticzymes Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hofseth Biocare ASA and Arcticzymes Technologies ASA, you can compare the effects of market volatilities on Hofseth Biocare and Arcticzymes Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hofseth Biocare with a short position of Arcticzymes Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hofseth Biocare and Arcticzymes Technologies.

Diversification Opportunities for Hofseth Biocare and Arcticzymes Technologies

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Hofseth and Arcticzymes is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Hofseth Biocare ASA and Arcticzymes Technologies ASA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcticzymes Technologies and Hofseth Biocare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hofseth Biocare ASA are associated (or correlated) with Arcticzymes Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcticzymes Technologies has no effect on the direction of Hofseth Biocare i.e., Hofseth Biocare and Arcticzymes Technologies go up and down completely randomly.

Pair Corralation between Hofseth Biocare and Arcticzymes Technologies

Assuming the 90 days trading horizon Hofseth Biocare ASA is expected to generate 1.31 times more return on investment than Arcticzymes Technologies. However, Hofseth Biocare is 1.31 times more volatile than Arcticzymes Technologies ASA. It trades about -0.1 of its potential returns per unit of risk. Arcticzymes Technologies ASA is currently generating about -0.17 per unit of risk. If you would invest  165.00  in Hofseth Biocare ASA on August 27, 2024 and sell it today you would lose (35.00) from holding Hofseth Biocare ASA or give up 21.21% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Hofseth Biocare ASA  vs.  Arcticzymes Technologies ASA

 Performance 
       Timeline  
Hofseth Biocare ASA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hofseth Biocare ASA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Arcticzymes Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Arcticzymes Technologies ASA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Hofseth Biocare and Arcticzymes Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hofseth Biocare and Arcticzymes Technologies

The main advantage of trading using opposite Hofseth Biocare and Arcticzymes Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hofseth Biocare position performs unexpectedly, Arcticzymes Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcticzymes Technologies will offset losses from the drop in Arcticzymes Technologies' long position.
The idea behind Hofseth Biocare ASA and Arcticzymes Technologies ASA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments